Report Overview
Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Antacids market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Antacids market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Antacids market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Antacids products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Antacids products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Antacids market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Antacids development has been the leading industry trend of Antacids market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Antacids Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Proton Pump Inhibitor, H2 Antagonist, Acid Neutralizers, Other |
| By Application Outlook |
Tablet, Liquid, Powder, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
WellSpring Pharm, Private Lable, GSK, Johnson & Johnson, Novartis Consurmer Health, Boehringer Ingelheim Pharm, GlaxoSmithKline, Procter & Gamble, Pfizer, First Aid Only |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- WellSpring Pharm
- Private Lable
- GSK
- Johnson & Johnson
- Novartis Consurmer Health
- Boehringer Ingelheim Pharm
- GlaxoSmithKline
- Procter & Gamble
- Pfizer
- First Aid Only
ANTACIDS Market, By Type
- Proton Pump Inhibitor
- H2 Antagonist
- Acid Neutralizers
- Other
ANTACIDSMarket, By Application
- Tablet
- Liquid
- Powder
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table Of Contents
Table of Contents
1 Antacids Market Overview
1.1 Antacids Product Overview
1.2 Antacids Market Segment by Type
1.2.1 Proton Pump Inhibitor
1.2.2 H2 Antagonist
1.2.3 Acid Neutralizers
1.3 Global Antacids Market Size by Type
1.3.1 Global Antacids Sales and Growth by Type
1.3.2 Global Antacids Sales and Market Share by Type (2013-2018)
1.3.3 Global Antacids Revenue and Market Share by Type (2013-2018)
1.3.4 Global Antacids Price by Type (2013-2018)
2 Global Antacids Market Competition by Company
2.1 Global Antacids Sales and Market Share by Company (2013-2018)
2.2 Global Antacids Revenue and Share by Company (2013-2018)
2.3 Global Antacids Price by Company (2013-2018)
2.4 Global Top Players Antacids Manufacturing Base Distribution, Sales Area, Product Types
2.5 Antacids Market Competitive Situation and Trends
2.5.1 Antacids Market Concentration Rate
2.5.2 Global Antacids Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Antacids Company Profiles and Sales Data
3.1 WellSpring Pharm
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Antacids Product Category, Application and Specification
3.1.3 WellSpring Pharm Antacids Sales, Revenue, Price and Gross Margin(2013-2018)
3.1.4 Main Business Overview
3.2 Private Lable
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Antacids Product Category, Application and Specification
3.2.3 Private Lable Antacids Sales, Revenue, Price and Gross Margin(2013-2018)
3.2.4 Main Business Overview
3.3 GSK
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Antacids Product Category, Application and Specification
3.3.3 GSK Antacids Sales, Revenue, Price and Gross Margin(2013-2018)
3.3.4 Main Business Overview
3.4 Johnson & Johnson
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Antacids Product Category, Application and Specification
3.4.3 Johnson & Johnson Antacids Sales, Revenue, Price and Gross Margin(2013-2018)
3.4.4 Main Business Overview
3.5 Novartis Consurmer Health
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Antacids Product Category, Application and Specification
3.5.3 Novartis Consurmer Health Antacids Sales, Revenue, Price and Gross Margin(2013-2018)
3.5.4 Main Business Overview
3.6 Boehringer Ingelheim Pharm
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Antacids Product Category, Application and Specification
3.6.3 Boehringer Ingelheim Pharm Antacids Sales, Revenue, Price and Gross Margin(2013-2018)
3.6.4 Main Business Overview
3.7 GlaxoSmithKline
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Antacids Product Category, Application and Specification
3.7.3 GlaxoSmithKline Antacids Sales, Revenue, Price and Gross Margin(2013-2018)
3.7.4 Main Business Overview
3.8 Procter & Gamble
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Antacids Product Category, Application and Specification
3.8.3 Procter & Gamble Antacids Sales, Revenue, Price and Gross Margin(2013-2018)
3.8.4 Main Business Overview
3.9 Pfizer
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Antacids Product Category, Application and Specification
3.9.3 Pfizer Antacids Sales, Revenue, Price and Gross Margin(2013-2018)
3.9.4 Main Business Overview
3.10 First Aid Only
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Antacids Product Category, Application and Specification
3.10.3 First Aid Only Antacids Sales, Revenue, Price and Gross Margin(2013-2018)
3.10.4 Main Business Overview
4 Antacids Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Antacids Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Antacids Sales and Revenue by Regions
4.2.1 Global Antacids Sales and Market Share by Regions (2013-2018)
4.2.2 Global Antacids Revenue and Market Share by Regions (2013-2018)
4.2.3 Global Antacids Sales, Revenue, Price and Gross Margin (2013-2018)
4.3 North America Antacids Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Antacids Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Antacids Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Antacids Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Antacids Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Antacids Application/End Users
5.1 Antacids Segment by Application
5.1.1 Tablet
5.1.2 Liquid
5.1.3 Powder
5.2 Global Antacids Product Segment by Application
5.2.1 Global Antacids Sales by Application
5.2.2 Global Antacids Sales and Market Share by Application (2013-2018)
6 Global Antacids Market Forecast
6.1 Global Antacids Sales, Revenue Forecast (2018-2025)
6.1.1 Global Antacids Sales and Growth Rate Forecast (2018-2025)
6.1.1 Global Antacids Revenue and Growth Rate Forecast (2018-2025)
6.2 Global Antacids Forecast by Regions
6.2.1 North America Antacids Sales and Revenue Forecast (2018-2025)
6.2.2 Europe Antacids Sales and Revenue Forecast (2018-2025)
6.2.3 Asia-Pacific Antacids Sales and Revenue Forecast (2018-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Antacids Sales and Revenue Forecast (2018-2025)
6.2.5 Middle East and Africa Antacids Sales and Revenue Forecast (2018-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Antacids Forecast by Type
6.3.1 Global Antacids Sales and Revenue Forecast by Type (2018-2025)
6.3.2 Proton Pump Inhibitor Gowth Forecast
6.3.3 H2 Antagonist Gowth Forecast
6.4 Antacids Forecast by Application
6.4.1 Global Antacids Sales Forecast by Application (2018-2025)
6.4.2 Global Antacids Forecast in Tablet
6.4.3 Global Antacids Forecast in Liquid
7 Antacids Upstream Raw Materials
7.1 Antacids Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Antacids Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer